Search results
ASCO 2024: Oncologists support Belong.Life’s AI cancer mentor Dave
Medical Device Network via Yahoo Finance· 1 day agoBelong.Life has received validation from practising oncologists for the company's conversational AI...
Blood RNA Biomarkers Identify Bacterial and Biofil | Newswise
Newswise· 6 days agoAbstract Purpose: Secondary opportunistic coinfections are a significant contributor to morbidity and mortality in intensive care unit (ICU) patients
Children’s Books: ‘Good Night, Good Beach’
The Wall Street Journal· 1 day agoThe text consists of short paragraphs set among the illustrations so that readers will need to hop about, as it were, as they go. Muted colors and a...
Red Flags
The Dispatch via Yahoo News· 20 hours agoOn the other hand, I can believe that the two flags were displayed as a pro-Trump political statement. There’d be nothing unusual in 2024 in the abstract...
Master planner writes that MBTA Zoning Law creates positive impacts on public health
Gannett via AOL· 10 hours agoNow we are seeing them firsthand, manifesting as crumbling shorelines, crippling drought, heat...
I was a millionaire by the age of 30. As preteens, my kids learned how to use debit cards, and I...
Business Insider· 7 hours agoDavid Ciccarelli was a millionaire by the time he was 30 and now has four kids. He teaches them to...
5 times royals served as page boys and bridesmaids: From Harry to Charlotte
Newsweek· 7 hours agoFor members of the royal family, their presence at weddings can be both a blessing and a curse. For...
Merus Clears Wall Street's Bar With Cancer Data
Barrons.com· 1 day agoMerus appears to have cleared the bar set by Wall Street for its highly watched cancer-treatment candidate. The company posts an abstract for its head...
The Ludicrous System That Makes It So Hard to Fight Crime in DC
Politico via Yahoo News· 1 day agoThe issue, for the locals, isn’t abstract crime-fighting theory. It’s raw numbers: A staggering 20 percent of the judgeships in D.C. Superior Court have been vacant for months ...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
FOX21 Colorado Springs· 2 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...